4.4 Article

Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese:: roles of UGT1A1*6 and*28

Hironobu Minami et al.

PHARMACOGENETICS AND GENOMICS (2007)

Article Oncology

New guidelines to evaluate the response to treatment in solid tumors

F Duffaud et al.

BULLETIN DU CANCER (2000)

Article Oncology

New guidelines to evaluate the response to treatment in solid Tumors

P Therasse et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)